2010 EFNS/PNS副蛋白血症性脱髓鞘神经病指南(第一次修订)

发布日期:
2010-09-01
英文标题:
European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies
出处:
Journal of the Peripheral Nervous System.2010;15:185–195.
摘要:

 

The aim of this guideline is to update the 2006 EFNS/PNS guidelineon management of patients with a demyelinating neuropathy and a paraprotein(paraproteinemic demyelinating neuropathy [PDN]) by review of evidence and expertconsensus. In the absence of adequate evidence, the panel agreed on good practicepoints:

(1) patients with PDN should be investigated for a malignant plasma cell dyscrasia;

 (2) a monoclonal gammopathy of undetermined significance is more likely to be causing the neuropathy if it is immunoglobulin (Ig)M, anti-neural antibodies are present, and the clinical phenotype is chronic distal sensory neuropathy;

(3) patients with IgM PDN usually have predominantly distal sensory impairment, prolonged distal motor latencies, and often anti-myelin-associated glycoprotein antibodies;

(4) IgM PDN may respond to immunomodulatory therapies. Their potential benefit should be balanced against possible side effects and the usually slow disease progression;

(5) IgG and IgA PDN may be indistinguishable from chronic inflammatory demyelinating polyradiculoneuropathy; and

 (6) Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, and Skin changes syndrome is a multi-system malignant PDN.

展开

部分内容仅可在
临床指南app 查看下载

阅读免费指南
发送到邮箱

收藏

分享

评论
提交评论
/ 没有更多了 /
上传者信息
lzliuzhuo
于2012-11-11上传
编者信息
欧洲神经科学协会联盟

欧洲神经科协会联盟是获得整个欧洲的神经学家支持的联合组织。目前有44个欧洲国家的神经协会注册会员,注册的神经学家超过19,000名。该学会致力于鼓励欧洲国家的神经系统协会之间的合作,加强基础神经科学和临床神经科学的融合,促进双向转化研究,推进神经病学与发展与神经系统疾病患者的医疗护理。其官方期刊是European Journal of Neurology

置顶